Skip to main content

Royan Ajay's Form 4 filing

Fractyl Health, Inc. (GUTS) · filed Feb 8, 2024

Accession no.
0000950170-24-012838
Filed
Feb 8, 2024
Trade date
Feb 6, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 5 derivative transactions. Open-market purchases total $5.00M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Royan AjayCIK 0001875614Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 6, 2024Common StockCConversionAcquired+5,160,301––5,160,301Indirect
Feb 6, 2024Common StockCConversionAcquired+918,567––918,567Indirect
Feb 6, 2024Common StockPPurchaseAcquired+333,333$15.00+$4,999,9951,251,900Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 6, 2024Common StockCConversionDisposed−1,875,938––0Indirect
Feb 6, 2024Common StockCConversionDisposed−3,030,193––0Indirect
Feb 6, 2024Common StockCConversionDisposed−254,170––0Indirect
Feb 6, 2024Common StockCConversionDisposed−173,821––0Indirect
Feb 6, 2024Common StockCConversionDisposed−744,746––0Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)